Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death

Cell Death and Differentiation

Volumn 14, Issue 2, 2007, Pages 318-326

  Li, Z ^a,b   Zhang, J ^b   Liu, Z ^a   Woo, C W ^a,c   Thiele, C J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

^c College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CISPLATIN; ETOPOSIDE; MITOGEN ACTIVATED PROTEIN KINASE; PACLITAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL PROTECTION; CELL SURVIVAL; DOWN REGULATION; GENE SILENCING; GENETIC TRANSFECTION; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTINEOPLASTIC AGENTS; APOPTOSIS REGULATORY PROTEINS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DEATH; CISPLATIN; DOWN-REGULATION; ENZYME ACTIVATION; ETOPOSIDE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR MIMICRY; NEUROBLASTOMA; PACLITAXEL; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS; RECEPTOR, TRKB; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 33846219461     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401983     Document Type: Article

References (46)

1. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP et al. (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466-1477.
2. Nakagawara A, Arima-Nakagawara M, Scavarda NJ, Azar CG, Cantor AB, Brodeur GM (1993) Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 328: 847-854.
3. Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS (1997) Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 19: 93-101.
4. Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM (1994) Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 14: 759-767.
5. Huang EJ, Reichardt LF (2003) Trk receptors: Roles in neuronal signal transduction. Annu Rev Biochem 72: 609-642.
6. Scala S, Wosikowski K, Giannakakou P, Valle P, Biedler JL, Spengler BA et al. (1996) Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity. Cancer Res 56: 3737-3742.
7. Middlemas DS, Kihl BK, Zhou L, Zhu X (1999) Brain-derived neurotrophic factor promotes survival and chemoprotection of human neruoblastoma cells. J Biol Chem 274: 16451-16460.
8. Jaboin J, Kim CJ, Kaplan DR, Thiele CJ (2002) Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3′-kinase pathway. Cancer Res 62: 6756-6763.
9. Li Z, Jaboin J, Dennis PA, Thiele CJ (2005) Genetic and Pharmcologic Identification of Akt as a Mediator of Brain-Derived Neurotrophic Factor/ TrkB Rsecue of Neuroblastoma Cells from Chemotherapy-Induced cell death. Cancer Res 65: 2070-2075.
10. Burgering BM, Coffer PJ (1995) Protein kinase B(c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602.
11. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687-689.
12. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E et al. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321.
13. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA et al. (1997) The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389: 994-999.
14. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM (1999) Direct control of the frokhead transcription factor AFX by protein kinase B. Nature 398: 630-634.
15. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
16. Zheng WH, Kar S, Quirion R (2000) Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells. J Biol Chem 275: 39152-39158.
17. Shin I, Bakin AV, Rodeck U, Brunet A, Arteaga CL (2001) Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1. Mol Biol Cell 12: 3328-3339.
18. Kashii Y, Uchida M, Kirito K, Tanaka M, Nishijima K, Toshima M et al. (2000) A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood 96: 941-949.
19. Abid MR, Guo S, Minami T, Spokes KC, Ueki K, Skurk C et al. (2004) Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells. Arterioscler Thromb Vasc Biol 24: 294-300.
20. Siegel RM, Chan FK, Chun HJ, Lenardo MJ (2000) The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 1: 469-474.
21. Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ (2000) Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 10: 1201-1204.
22. Bouillet P, Zhang LC, Huang DC, Webb GC, Bottema CD, Shore P et al. (2001) Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim. Mamm Genome 12: 163-168.
23. Dijkers PF, Birkenkamp KU, Lam EW, Thomas NS, Lammers JW, Koenderman L et al. (2002) FKHRL1 can act as a critical effector of cell death induced by cytokine withdrawal: Protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J Cell Biol 156: 531-542.
24. Tan TT, Degenhardt K, Nelson DA, Beaudoin B, Nieves-Neira W, Bouillet P et al. (2005) Key roles of Bim-driven apoptosis in epithelial tumors and rational chemotherapy. Cancer Cell 7: 227-238.
25. Egle A, Harris AW, Bouillet P, Cory S (2004) Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc Natl Acad Sci USA 101: 6164-6169.
26. Gilley J, Coffer PJ, Ham J (2003) FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 162: 613-622.
27. Shinjyo T, Kuribara R, Inukai T, Hosoi H, Kinoshita T, Miyajima A et al. (2001) Downregulation of Bim, a proapoptotic Relative of Bcl-2, Is a Pivotal Step in Cytokine-Initiated Survival Signaling in Murine Hematopoietic Progenitors. Mol Cellular Bio 21: 854-864.
28. Weston CR, Balmanno K, Chalmers C, Hadfield K, Molton SA, Ley R et al. (2003) Activation of ERK1/2 by deltaRaf-1:ER* represses Bim expression independently of the JNK or PI3K pathways. Oncogene 22: 1281-1293.
29. Harris CA, Johnson Jr EM (2001) BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J Biol Chem 276: 37754-37760.
30. Harris C, Maroney AC, Johnson Jr EM (2002) Identification of JNK-dependent and -independent components of cerebellar granule neuron apoptosis. J Neurochem 83: 992-1001.
31. Sugatani T, Hruska KA (2005) Akt1/Akt2 and mammalian target of rapamycin/ Bim play critical roles in osteoclast differentiation and survival, respectively, while Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem 280: 3583-3589.
32. Graos M, Almeida AD, Chatterjee S (2005) Growth factor-dependent phosphorylation of Bim in mitosis. Biochemical J 388: 185-194.
33. Harada H, Quearry B, Ruiz-Vela A, Korsmeyer SJ (2004) Survival factor-induced extracellular signal-regulated kinase phosphorylates Bim, inhibiting its association with BAX and proapoptotic activity. PNAS 101: 15313-15317.
34. Urbich C, Knau A, Fichtlscherer S, Walter DH, Bruhl T, Potente M et al. (2005) FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB 19: 974-976.
35. Li R, Moudgil T, Ross HJ, Hu HM (2005) Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim. Cell Death Differ 12: 292-303.
36. Sunters A, Fernandez de Mattos S, Stahl M, Brosens JJ, Zoumpoulidou G, Saunders CA et al. (2003) FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxeltreated breast cancer cell lines. J Biol Chem 278: 49795-49805.
37. Puthalakath H, Huang DC (1999) The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell 3: 287-296.
38. O'Reilly LA, Cullen L, Visvader J, Lindeman GJ, Print C, Bath ML et al. (2000) The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells. Am J Pathol 157: 449-461.
39. Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: A play in three Akts. Genes Dev 13: 2905-2927.
40. Zhu W, Bijur GN, Styles NA, Li X (2004) Regulation of FOXO3a by brain-derived neurotrophic factor in differentiated human SH-SY5Y neuroblastoma cells. Brain Res Mol Brain Res 126: 45-56.
41. Biswas SC, Greene LA (2002) Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3 (BH3) domain-only protein Bim and suppresses its proapoptotic activity by phosphorylation. J Biol Chem 277: 49511-49516.
42. Lavoie JF, Lesauteur L, Kohn J, Wong J, Furtoss O, Thiele CJ et al. (2005) TrkA induces apoptosis of neuroblastoma cells and does so via p53-dependent mechanism. J Biol Chem 280: 29199-29207.
43. Finnberg N, El-Deiry WS (2005)Paclitaxel and velcade: The rationale for a combo. Cancer Biol Ther 4: 631-634.
44. Adjei AA, Hidalgo M (2005) Intracellular signal transduction pathway proteins as targets for cancer therapy. J Clin Oncol 23: 5386-5403.
45. Kim CJ, Matsuo T, Lee KH, Thiele CJ (1999) Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells. Am J Pathol 155: 1661-1670.
46. Bokemeyer D, Sorokin A, Yan M, Ahn NG, Templeton DJ, Dunn MJ (1996) Induction of mitogen-activated protein kinase phosphatase 1 by the stress-activated protein kinase signaling pathway but not by extracellular signal-regulated kinase in fibroblasts. J Biol Chem 271: 639-642.